Argos Therapeutics to Present at the Annual Sachs Immuno-Oncology: BD&L and Investment Forum
May 29, 2015 at 08:31 AM EDT
Argos Therapeutics Inc. (Nasdaq: ARGS) ("Argos"), an immuno-oncology company focused on the development and commercialization of fully ...